Panitumumab Use in Metastatic Colorectal Cancer and Patterns of KRAS Testing: Results from a Europe-Wide Physician Survey and Medical Records Review.

From 2008-2013, the European indication for panitumumab required that patients' tumor KRAS exon 2 mutation status was known prior to starting treatment. To evaluate physician awareness of panitumumab prescribing information and how physicians prescribe panitumumab in patients with metastatic co...

Full description

Bibliographic Details
Main Authors: Jörg Trojan, Laurent Mineur, Jiří Tomášek, Etienne Rouleau, Pavel Fabian, Giovanna de Maglio, Pilar García-Alfonso, Giuseppe Aprile, Aliki Taylor, George Kafatos, Gerald Downey, Jan-Henrik Terwey, J Han van Krieken
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4619650?pdf=render